Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 60 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9630932

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  2. US 9629385

    Dietary composition containing cistanche deserticola polysaccharide with inhibitory effects on colon cancer

    INFINITUS (CHINA) COMPANY LTD. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  3. US 9630914

    Multitarget FAAH and COX inhibitors and therapeutical uses thereof

    The Regents of the University of California · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  4. US 9624170

    4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  5. US 9624268

    Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

    Protagonist Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  6. US 9624238

    4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  7. US 9624229

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  8. US 9624228

    Inhibitors of ERK and methods of use

    Kura Oncology, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  9. US 9616047

    Inhibitors of beta-catenin in treatment of colorectal cancer

    Regents of the University of Minnesota · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted
  10. US 9611292

    Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  11. US 9611258

    Dual MEK/PI3K inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  12. US 9603829

    HSP90 inhibitors with modified toxicity

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  13. US 9598424

    Heteroarylamide inhibitors of TBK1

    Takeda Pharmaceutical Company Limited · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  14. US 9598404

    Deoxycytidine kinase inhibitors

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  15. US 9598370

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  16. US 9596855

    Small molecule inhibitors of biofilm formation and the novel use of previously identified compounds for inhibition of biofilm formation and applications for drug therapy and medical device coating

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  17. US 9593110

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  18. US 9592232

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  19. US 9586890

    Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods

    Northwestern University · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  20. US 9585882

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  21. US 9586975

    Macrocyclic salt-inducible kinase inhibitors

    Oncodesign SA · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  22. US 9580427

    Kinase inhibitors

    The Regents of the University of California · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  23. US 9580430

    9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  24. US 9580438

    Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

    4SC DISCOVERY GMBH · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted